Current Science Research Bulletin

The aim of the research was to evaluate the troponin and glycated hemoglobin (HbA1c) levels in individuals with diabetes. The study's 100 diabetic patients were divided into a control group of 100 healthy individuals between the ages of 55 and 75. Blood samples were tested using ELISA. The findings demonstrated that hemoglobin HbA1c l and troponins were significantly higher in diabetics than in the control group (p<0.05). These findings most likely demonstrate a favorable correlation between troponins and hemoglobin HbA1c in diabetics.

.

1. Nichols GA, Schroeder EB, Karter AJ, (2015)Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol.  Jan 1;181(1):32–39
2. Maruthur NM(2013).. The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep. ;13(6):786–94. 
3. Inzucchi SE, Bergenstal RM, Buse JB, (2012). Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Spectrum. ;25(3):154–71
4. Duckworth W, Abraira C, Moritz T, (2009). Glucose control and vascular complications in veterans with type 2 diabetes. The New England journal of medicine.  8;360(2):129–39. 
5. Papademetriou V, Lovato L, Doumas M, (2014). Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int.  17; 66-68
6. Hinkle J, Cheever K. Brunner &amp; Suddarth's Handbook of Laboratory and Diagnostic Tests. 2nd Ed, Kindle. Philadelphia: Wolters Kluwer Health, Lippincott Williams &amp; Wilkins; c2014. Troponin; p. 492-3.
7. Apple FS, Collinson PO. IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays Clin Chem. 2012;58(1):54–61.
8. Sethi A, Bajaj A, Malhotra G, Arora RR, Khosia S(2014). Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review. Vasc Health Risk Manag. 10:435–50.
9. Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM(2019).. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation 139(23):2642-2653
10. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK(2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 11:95–104.
11. Bolen S, Feldman L, Vassy J, (2007). Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med.  18;147(6):386–99. 
12. Maynard SJ, Menown IB, Adgey AA. (2019). Troponin T or troponin I as cardiac markers in ischaemic heart disease. Heart; 83(4):371-373. 
13. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–67.
14. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C(2012). High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J.;33(5):579–86.
15. Bennett WL, Maruthur NM, Singh S, (2011)Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med.  3;154(9):602–13
16. Turner LW, Nartey D, Stafford RS, (2012)Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care. 2014 Apr;37(4):985–92. 
17. Ang SH, Thevarajah M, Alias Y, Khor SM (2015). Current aspects in hemoglobin A1c detection: a review. Clin Chim Acta. 439:202–211. 
18. Radin MS(2014). Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med. 29(2):388–394